Carfilzomib
CAS 868540-17-4
In Stock
Carfilzomib
Cat. No. ANT-CRF-000CAS 868540-17-4In Stock
Technical Data
Cat. No.ANT-CRF-000
CAS868540-17-4
Mol. FormulaC40H57N5O7
Mol. Weight719.91 g/mol
IUPAC(2S)-4-methyl-N-[(2S)-1-[[(2S)-4-methyl-1-[(2R)-2-methyloxiran-2-yl]-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]-4-phenylbutanoyl]amino]pentanamide
SMILESCC(C)C[C@@H](C(=O)[C@]1(CO1)C)NC(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC3=CC=CC=C3)NC(=O)CN4CCOCC4
InChIInChI=1S/C40H57N5O7/c1-27(2)22-32(36(47)40(5)26-52-40)42-39(50)34(24-30-14-10-7-11-15-30)44-38(49)33(23-28(3)4)43-37(48)31(17-16-29-12-8-6-9-13-29)41-35(46)25-45-18-20-51-21-19-45/h6-15,27-28,31-34H,16-26H2,1-5H3,(H,41,46)(H,42,50)(H,43,48)(H,44,49)/t31-,32-,33-,34-,40+/m0/s1
InChI KeyBLMPQMFVWMYDKT-NZTKNTHTSA-N
Purity99%
Description
Overview
Carfilzomib, sold under the brand name Kyprolis, is an anti-cancer medication acting as a selective proteasome inhibitor
Anant Labs manufacture and furnish high quality Carfilzomib impurities for global markets. Our Carfilzomib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
NACarfilzomib868540-17-4KyprolisPR-171NSC-75825272X6E3J5ARDTXSID4048690DTXCID0028616CHEBI:65347
